Three-dimensional structure of chymotrypsin inactivated with (2S)-N-acetyl-L-alanyl-L-phenylalanyl alpha-chloroethane: implications for the mechanism of inactivation of serine proteases by chloroketones.

The reaction of enantiomerically pure (2S)-N-acetyl-L-alanyl-L-phenylalanyl alpha-chloroethane with gamma-chymotrypsin was studied as a probe of the mechanism of inactivation of serine proteases by peptidyl chloroalkanes. It was determined crystallographically that the peptidyl chloroethane alkylates His57 with retention of configuration at the chiral center, indicating a double displacement mechanism. We think it likely that a Ser195-epoxy ether adduct is an intermediate on the inactivation pathway, although other possibilities have not been disproven. Kinetic data reported by others [Angliker et al. (1988) Biochem. J. 256, 481-486] indicate that the epoxy ether intermediate is not an irreversibly inactivated form of enzyme [a conclusion confirmed experimentally (Prorok et al. (1994) Biochemistry 33, 9784-9790)] and that both ring closure of the tetrahedral intermediate to form the epoxy ether and ring opening by His57 partially limit the first-order rate constant for inactivation, ki. The peptidyl chloroethyl derivative adopts a very different active site conformation from that assumed by serine proteases inactivated by peptidyl chloromethanes. Positioning the chloroethyl derivative into the conformation adopted by chloromethyl derivatives would cause the extra methyl group to make a bad van der Waals contact with the inactivator P2 carbonyl carbon, thereby preventing the formation of the invariant hydrogen bond between the inactivator P1 amide nitrogen and the carbonyl group of Ser214. We conclude that the unusual conformation displayed by the chloroethyl derivative is caused by steric hindrance between the extra methyl group and the rest of the inactivator chain.

[1]  E. Shaw,et al.  Synthesis and properties of peptidyl derivatives of arginylfluoromethanes. , 1988, The Biochemical journal.

[2]  Brian W. Matthews,et al.  An efficient general-purpose least-squares refinement program for macromolecular structures , 1987 .

[3]  H. Taguchi,et al.  Effect of thrombomodulin on the kinetics of the interaction of thrombin with substrates and inhibitors. , 1986, The Biochemical journal.

[4]  R. Verhé,et al.  Facile synthesis of 2-alkoxy-2-aryloxiranes , 1983 .

[5]  C. Brenner,et al.  The synthesis of inhibitors for processing proteinases and their action on the Kex2 proteinase of yeast. , 1993, The Biochemical journal.

[6]  D. Ringe,et al.  X-ray diffraction analysis of the inactivation of chymotrypsin by 3-benzyl-6-chloro-2-pyrone. , 1986, Biochemistry.

[7]  D. Banner,et al.  Crystallographic analysis at 3.0-A resolution of the binding to human thrombin of four active site-directed inhibitors. , 1994, The Journal of biological chemistry.

[8]  G A Petsko,et al.  Structure and activity of two photoreversible cinnamates bound to chymotrypsin. , 1990, Biochemistry.

[9]  D. Koshland,et al.  The formation of anhydrochymotrypsin by removing the elements of water from the serine at the active site. , 1966, Journal of the American Chemical Society.

[10]  Z. Luz,et al.  A Nuclear Magnetic Resonance Study of the Reversible Hydration of Aliphatic Aldehydes and Ketones. I. Oxygen-17 and Proton Spectra and Equilibrium Constants , 1967 .

[11]  B. Foxman,et al.  Chloroketone hydrolysis by chymotrypsin and N-methylhistidyl-57-chymotrypsin: implications for the mechanism of chymotrypsin inactivation by chloroketones. , 1994, Biochemistry.

[12]  C. Stevens,et al.  Epoxy Ethers. XIX. Reaction of 1,2-Epoxy-1-methoxy-2-methyl-1-phenylpropane with Amines , 1962 .

[13]  T. Liang,et al.  pH dependence of the inhibition of chymotrypsin by a peptidyl trifluoromethyl ketone. , 1989, Biochemistry.

[14]  E. Shaw,et al.  Evaluation of inhibitor constants and alkylation rates for a series of thrombin affinity labels. , 1985, Biochemical Journal.

[15]  E. Shaw,et al.  Synthesis of peptides of arginine chloromethyl ketone. Selective inactivation of human plasma kallikrein. , 1978, Biochemistry.

[16]  J. P. Malthouse,et al.  A study of the stabilization of tetrahedral adducts by trypsin and delta-chymotrypsin. , 1992, The Biochemical journal.

[17]  H. Klenk,et al.  Inhibition of furin-mediated cleavage activation of HIV-1 glycoprotein gpl60 , 1992, Nature.

[18]  W. Bode,et al.  Inhibition of trypsin by carbobenzyloxylysyl chloromethyl ketone: 13C NMR and x-ray diffraction analyses of the enzyme-inhibitor complex , 1986 .

[19]  Jones Ta,et al.  Diffraction methods for biological macromolecules. Interactive computer graphics: FRODO. , 1985, Methods in enzymology.

[20]  G. Cohen,et al.  Refined crystal structure of gamma-chymotrypsin at 1.9 A resolution. Comparison with other pancreatic serine proteases. , 1981, Journal of molecular biology.

[21]  M. Levitt,et al.  Aromatic Rings Act as Hydrogen Bond Acceptors , 2022 .

[22]  J. Kraut,et al.  Polypeptide halomethyl ketones bind to serine proteases as analogs of the tetrahedral intermediate. X-ray crystallographic comparison of lysine- and phenylalanine-polypeptide chloromethyl ketone-inhibited subtilisin. , 1976, The Journal of biological chemistry.

[23]  Stein Rl,et al.  Mechanism of inactivation of human leukocyte elastase by a chloromethyl ketone: kinetic and solvent isotope effect studies. , 1986 .

[24]  Thomas A. Steitz,et al.  Structure of crystalline α-chymotrypsin: III. Crystallographic studies of substrates and inhibitors bound to the active site of α-chymotrypsin , 1969 .

[25]  N. Kimpe,et al.  α-Haloketones,α-Haloaldehydes andα-Haloimines (1988) , 1988 .

[26]  A. Berger,et al.  On the size of the active site in proteases. I. Papain. , 1967, Biochemical and biophysical research communications.

[27]  E. Shaw,et al.  In vivo studies of a synthetic inhibitor of thrombin. , 1982, The Journal of laboratory and clinical medicine.

[28]  D. Ringe,et al.  Structure of chymotrypsin-trifluoromethyl ketone inhibitor complexes: comparison of slowly and rapidly equilibrating inhibitors. , 1990, Biochemistry.

[29]  R. Rando Chemistry and enzymology of kcat inhibitors. , 1974, Science.

[30]  S. Waley Kinetics of suicide substrates. Practical procedures for determining parameters. , 1985, The Biochemical journal.

[31]  G. Cohen,et al.  Substrate binding site in bovine chymotrypsin A-gamma. A crystallographic study using peptide chloromethyl ketones as site-specific inhibitors. , 1971, Biochemistry.

[32]  G A Petsko,et al.  Amino‐aromatic interactions in proteins , 1986, FEBS letters.

[33]  G. P. Hess,et al.  Studies of the activity of chymotrypsin. , 1970, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[34]  H. Paulsen,et al.  Konformationsanalyse, VIII. Tri‐axiale Konformation des 1‐(Tri‐O‐acetyl‐α‐D‐xylopyranosyl)‐imidazols im Kristall , 1974 .

[35]  E. Shaw,et al.  The inhibition of crotalase, a thrombin-like snake venom enzyme, by several peptide chloromethyl ketone derivatives. , 1981, Biochemical and biophysical research communications.

[36]  Roger E Bumgarner,et al.  Benzene Forms Hydrogen Bonds with Water , 1992, Science.

[37]  R. Corey,et al.  PRELIMINARY X-RAY DIFFRACTION STUDIES OF CRYSTAL FORMS OF FREE AND INHIBITED CHYMOTRYPSIN. , 1965, Biochimica et biophysica acta.

[38]  J. C. Warner,et al.  The kinetics of the reaction between the ethylene halohydrins and hydroxyl ion in water and mixed solvents. , 1948, Journal of the American Chemical Society.